Viewing StudyNCT04777539



Ignite Creation Date: 2024-05-06 @ 3:50 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04777539
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-19
First Post: 2021-02-23

Brief Title: Comparing the Safety and Benefit of Natalizumab Tysabri At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
Sponsor:
Organization: Nantes University Hospital

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 279
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Other
Time Perspective List:

Clinical Trial Statuses

Name
73061
Who Masked List: